• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,168.98 -150.57
( -0.21%)
Global Indices
Nasdaq
46,525.67 -61.07
(-0.13%)
Dow Jones
6,603.69 7.37
(0.11%)
Hang Seng
53,162.49 699.22
(1.33%)
Nikkei 225
10,436.29 71.50
(0.69%)
Forex
USD-INR
93.02 -0.15
(-0.16%)
EUR-INR
107.32 -0.65
(-0.60%)
GBP-INR
123.03 -0.78
(-0.63%)
JPY-INR
0.58 0.00
(-0.67%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
411.5542386
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
21.04
96400.78
EPS(TTM)
Face Value()
Div & Yield %
56.72
2
1.34
 

&hra cements ltd
Gallantt Ispat gains as Q3 PAT jumps 13% QoQ to Rs 100 cr
Feb 05,2026

On a consolidated basis, Gallantt Ispat’s net profit surged 12.92% to Rs 100.41 crore in Q3 FY26 as against Rs 88.92 crore in Q2 FY26.

Revenue from operations rallied 6% to Rs 1,073.58 crore in Q3 FY26 over Q2 FY26.

Profit before tax soared 19.45% to Rs 123.04 crore in Q3 FY26 over Q2 FY26.

On a year-on-year basis, the company’s consolidated net profit declined 11.66%, while revenue from operations fell 4% in Q3 FY26. Profit before tax stood at Rs 123.04 crore, down 25.49% from a year ago.

Gallantt Ispat is a leading iron and steel manufacturing company located in Eastern Uttar Pradesh. The company is engaged in the business of iron & steel, agro, power, and real estate.